ORIGINALS | |
Therapeutic drug monitoring of nivolumab in routine clinical practice. A pilot study
Manuel Sureda, Juan José Mata, Ana Catalán, Vanesa Escudero, Elena Martínez-Navarro, Joseba Rebollo Farm Hosp. 2020;44(3):81-6 |
|
Evaluation of adherence and clinical outcomes in patients undergoing allogeneic haematopoietic stem cell transplantation
Lorena García-Basas, Marina Sánchez-Cuervo, Esther Gómez de Salazar-López de Silanes, Cristina Pueyo-López, Claudia Núñez-Torrón-Stock, Pilar Herrera-Puente Farm Hosp. 2020;44(3):87-91 |
|
REVISIONS | |
Biosimilars of monoclonal antibodies in inflammatory diseases and cancer: current situation, challenges, and opportunities
Miguel Ángel Calleja-Hernández, José Manuel Martínez-Sesmero, Belén Santiago-Josefat Farm Hosp. 2020;44(3):100-8 |
|
ORIGINALS IN BRIEF | |
Patients in Nursing Homes: type 2 diabetes mellitus prevalence and its pharmacologic therapy
Idoia Beobide-Telleria, Silvia Martínez-Arrechea, Alexander Ferro-Uriguen, Javier Alaba-Trueba Farm Hosp. 2020;44(3):92-5 |
|
Real world study of pertuzumab-trastuzumabchemotherapy versus trastuzumab-chemotherapy in neoadjuvant treatment of breast cancer
Rocío Díaz-Acedo, Silvia Artacho-Criado, Mercedes Galván-Banqueri, Pilar López-Álvarez Farm Hosp. 2020;44(3):96-9 |
|
SPECIAL ARTICLE | |
Gender bias in therapeutic effort: from research to health care
María Teresa Ruiz-Cantero, Mar Blasco-Blasco, Elisa Chilet-Rosell, Ana M. Peiró Farm Hosp. 2020;44(3):109-13 |
|
Implementing barcode medication administration and smart infusion pumps is just the beginning of the safety journey to prevent administration errors
Christina Michalek, Stacy L. Carson Farm Hosp. 2020;44(3):114-21 |
|
ACKNOWLEDGEMENT | |
Standardization for safety: a feasible challenge
Silvia Manrique-Rodríguez, Cecilia M. Fernández-Llamazares Farm Hosp. 2020;44(3):79-80 |
|